Entrada Therapeutics
TRDA
$18.29
Share price
0.77%
Change (1 day)
-18.31%
Change (1 year)
Categories
Revenue for Entrada Therapeutics (TRDA)
Revenue in 2024 (TTM): NZ$0.35 Billion
According to Entrada Therapeutics's latest financial reports the company's current revenue (TTM 
) is NZ$0.36 Billion. an increase over the revenue in the year 2023 that were of NZ$0.20 Billion. The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.
Revenue history for Entrada Therapeutics from 2021 to 2024
Annual revenue
| Year | Revenue | Change |
|---|---|---|
| 2024 | NZ$0.37 B | 83.2% |
| 2023 | NZ$0.20 B | |
| 2022 | N/A | |
| 2021 | N/A |